EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Therapeutic Architecture of Chlorogenic Acids: Molecular Mechanisms in Chronic Disease Prevention

Gabriela Morales-Lima iD, Mariana Esteves Felix Penha iD, Beatriz Silva Piristrello iD, Scarlett Cristina Mendes da Silva iD, Giuseppina Negri iD, Carlos A Toro, Fúlvio Rieli Mendes iD, Giulio Maria Pasinetti

Nutrients · 04.08.2026 · 18 (15) · 2542

DOI: 10.3390/nu18152542 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 04.08.2026. Verfasst von Gabriela Morales-Lima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Natural and Human Sciences, Universidade Federal do ABC, São Bernardo do Campo 09606-045, SP, Brazil. Hauptthemen laut MEDLINE: Chlorogenic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NCCIH NIH HHS, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review examines the structural variety, distribution, and physicochemical properties of chlorogenic acids (CGAs), identifying coffee and green coffee as the leading dietary sources of these compounds. Preclinical studies indicate that plant-derived phenolic compounds exhibit strong antioxidant, anti-inflammatory, neuroprotective, cardioprotective, and antidiabetic effects across various disease models. The biological effectiveness of CGAs is attributed to their modulation of cellular signaling pathways, particularly by activating the erythroid 2-related factor 2 antioxidant defense mechanism and inhibiting the pro-inflammatory nuclear factor kappa B pathway. The regulation of the energy-sensing Sirtuin 1 and AMP-activated protein kinase pathways further enhances these therapeutic effects. In the gastrointestinal tract, CGAs serve as key modulators of the microbiota–gut–brain axis by exerting prebiotic-like effects, lowering the Firmicutes/Bacteroidetes ratio, promoting the production of short-chain fatty acids, and preserving gut barrier integrity. Some preclinical studies with coffee, Ilex paraguariensis, Eugenia uniflora, and other CGAs-rich extracts are also discussed. However, despite strong preclinical evidence, translating these findings into human clinical settings remains inconsistent due to significant individual differences in gut microbiota metabolism and the confounding effects of other components in dietary supplements, such as caffeine. Considering this, the review will first explore the molecular mechanisms supporting the potential development of CGAs as preventive interventions, while also discussing current human trials demonstrating selective improvements in neurological, cardiovascular, and metabolic functions. It will also highlight a historical limitation: the lack of studies on the bioavailability, bioactivity, and efficacy of isolated CGAs. The review will conclude by addressing the constraints of clinical studies, emphasizing the urgent need for future precision nutrition frameworks that employ standardized CGAs formulations to enhance potential therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlorogenic AcidHumansChronic DiseaseAnimalsGastrointestinal MicrobiomeCoffeeAntioxidantsDietary SupplementsPlant ExtractsSignal TransductionNeuroprotective Agents

Stichwörter der Autor:innen

Ilex paraguariensisNrf2 pathwaychlorogenic acidscoffeegut–brain axispolyphenols

Substanzen

Chlorogenic AcidCoffeeAntioxidantsPlant ExtractsNeuroprotective Agents

Autor:innen und Institutionen

  • Center for Natural and Human Sciences, Universidade Federal do ABC, São Bernardo do Campo 09606-045, SP, Brazil.
  • Spinal Cord Damage Research Center, James J. Peters VA Medical Center, Bronx, NY 10468, USA.
  • VA Sequencing Collaborations United for Research and Epidemiology (seqCURE), James J. Peters VA Medical Center, Bronx, NY 44106, USA.
  • The Bronx Veterans Medical Research Foundation, Bronx, NY 10468, USA.
  • Geriatrics Research, Education and Clinical Center (GRECC), James J. Peters VA Medical Center, Bronx, NY 10648, USA.

ORCID-Profile: Gabriela Morales-Lima, Mariana Esteves Felix Penha, Beatriz Silva Piristrello, Scarlett Cristina Mendes da Silva, Giuseppina Negri, Fúlvio Rieli Mendes

Förderung

  • BLRD VA
  • NCCIH NIH HHS
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • São Paulo Research Foundation
  • National Center for Complementary and Integrative Health
  • VHA

Zitieren

APA

Morales-Lima, G., Penha, M. E. F., Piristrello, B. S., da Silva, S. C. M., Negri, G., Toro, C. A., Mendes, F. R., & Pasinetti, G. M. (2026). The Therapeutic Architecture of Chlorogenic Acids: Molecular Mechanisms in Chronic Disease Prevention. Nutrients, 18(15), 2542. https://doi.org/10.3390/nu18152542

Vancouver

Morales-Lima G, Penha MEF, Piristrello BS, da Silva SCM, Negri G, Toro CA, et al. The Therapeutic Architecture of Chlorogenic Acids: Molecular Mechanisms in Chronic Disease Prevention. Nutrients. 2026;18(15):2542. doi:10.3390/nu18152542

BibTeX
@article{MoralesLima2026,
  author = {Morales-Lima, Gabriela and Penha, Mariana Esteves Felix and Piristrello, Beatriz Silva and da Silva, Scarlett Cristina Mendes and Negri, Giuseppina and Toro, Carlos A and Mendes, Fúlvio Rieli and Pasinetti, Giulio Maria},
  title = {The Therapeutic Architecture of Chlorogenic Acids: Molecular Mechanisms in Chronic Disease Prevention},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2542},
  doi = {10.3390/nu18152542}
}
Kostenlos starten →